Cargando…

Newcastle Disease Virus Hemagglutinin Neuraminidase as a Potential Cancer Targeting Agent

The hemagglutinin-neuraminidase (HN) protein of Newcastle disease virus (NDV) with its immunotherapeutic activities and sialic acid binding abilities is a promising cancer adjuvant. The HN was surfaced displayed on Lactococcus lactis and its cancer targeting ability was investigated via attachment t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Baradaran, Ali, Yusoff, Khatijah, Shafee, Norazizah, Rahim, Raha Abdul
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4749367/ https://www.ncbi.nlm.nih.gov/pubmed/26918060 http://dx.doi.org/10.7150/jca.13566

Ejemplares similares

Viral persistence in colorectal cancer cells infected by Newcastle disease virus
por: Chia, Suet-Lin, et al.
Publicado: (2014)

Reduced Newcastle disease virus-induced oncolysis in a subpopulation of cisplatin-resistant MCF7 cells is associated with survivin stabilization
por: Jamal, Mohd-Hafifi, et al.
Publicado: (2012)

Recombinant Enterovirus 71 Viral Protein 1 Fused to a Truncated Newcastle Disease Virus NP (NPt) Carrier Protein
por: Mustafa, Suhaili, et al.
Publicado: (2020)

Mapping of three antigenic sites on the haemagglutinin-neuraminidase protein of Newcastle disease virus
por: Yusoff, Khatijah, et al.
Publicado: (1988)

Identification of a potential neutralizing linear epitope of hemagglutinin-neuraminidase in Newcastle disease virus
por: Jin, Zhongyuan, et al.
Publicado: (2021)

Hemagglutinin-neuraminidase gene of genotype VII Newcastle disease virus strains isolated in Japan
por: MASE, Masaji
Publicado: (2021)

Improved immunogenicity of Newcastle disease virus inactivated vaccine following DNA vaccination using Newcastle disease virus hemagglutinin-neuraminidase and fusion protein genes
por: Firouzamandi, Masoumeh, et al.
Publicado: (2016)

Positive selection in the hemagglutinin-neuraminidase gene of Newcastle disease virus and its effect on vaccine efficacy
por: Gu, Min, et al.
Publicado: (2011)

Different Origins of Newcastle Disease Virus Hemagglutinin-Neuraminidase Protein Modulate the Replication Efficiency and Pathogenicity of the Virus
por: Jin, Ji-hui, et al.
Publicado: (2017)

Transient expression of fusion and hemagglutinin-neuraminidase epitopes of Newcastle disease virus in maize as a potent candidate vaccine
por: Shahriari, Amir Ghaffar, et al.
Publicado: (2021)

Induction of apoptosis in MCF-7 cells by the hemagglutinin-neuraminidase glycoprotein of Newcastle disease virus Malaysian strain AF2240
por: GHRICI, MOHAMED, et al.
Publicado: (2013)

Anti-Tumor Effects of an Oncolytic Adenovirus Expressing Hemagglutinin-Neuraminidase of Newcastle Disease Virus in Vitro and in Vivo
por: He, Dongyun, et al.
Publicado: (2014)

Screening and mechanistic study of key sites of the hemagglutinin-neuraminidase protein related to the virulence of Newcastle disease virus
por: Yan, Chuanqi, et al.
Publicado: (2020)

Expression and characterization of hemagglutinin–neuraminidase protein from Newcastle disease virus in Bacillus subtilis WB800
por: Shafaati, Mohammadreza, et al.
Publicado: (2022)

Newcastle disease virus degrades HIF-1α through proteasomal pathways independent of VHL and p53
por: Abd-Aziz, Noraini, et al.
Publicado: (2016)

Molecular characterization of hemagglutinin-neuraminidase fragment gene of Newcastle disease virus isolated from periodically-vaccinated farms
por: Triosanti, Lucia S., et al.
Publicado: (2018)

Structure of the Ulster Strain Newcastle Disease Virus Hemagglutinin-Neuraminidase Reveals Auto-Inhibitory Interactions Associated with Low Virulence
por: Yuan, Ping, et al.
Publicado: (2012)

Identification of the amino acids residues involved in hemagglutinin-neuraminidase of Newcastle disease virus binding to sulfated Chuanmingshen violaceum polysaccharides
por: Song, Xu, et al.
Publicado: (2021)

Etymologia: Hemagglutinin and Neuraminidase
por: Henry, Ronnie, et al.
Publicado: (2018)

Improving the potency of DNA vaccine against Chicken Anemia Virus (CAV) by fusing VP1 protein of CAV to Marek's Disease Virus (MDV) Type-1 VP22 protein
por: Moeini, Hassan, et al.
Publicado: (2011)

Therapeutic targeting of liver cancer with a recombinant DNA vaccine containing the hemagglutinin-neuraminidase gene of Newcastle disease virus via apoptotic-dependent pathways
por: Chen, Li-Gang, et al.
Publicado: (2016)

Immunomodulatory Effects of Newcastle Disease Virus AF2240 Strain on Human Peripheral Blood Mononuclear Cells
por: Lam, Han Yuen, et al.
Publicado: (2014)

Characterization of Natural and Synthetic Sialoglycans Targeting the Hemagglutinin-Neuraminidase of Mumps Virus
por: Forgione, Rosa Ester, et al.
Publicado: (2021)

Safety and Clinical Usage of Newcastle Disease Virus in Cancer Therapy
por: Lam, Han Yuen, et al.
Publicado: (2011)

Design, Synthesis, and Antiviral Evaluation of Sialic Acid Derivatives as Inhibitors of Newcastle Disease Virus Hemagglutinin-Neuraminidase: A Translational Study on Human Parainfluenza Viruses
por: Rota, Paola, et al.
Publicado: (2023)

Protection of chickens from Newcastle disease with a recombinant baculovirus subunit vaccine expressing the fusion and hemagglutinin-neuraminidase proteins
por: Lee, Youn-Jeong, et al.
Publicado: (2008)

Exploring the Prospects of Engineered Newcastle Disease Virus in Modern Vaccinology
por: Bello, Muhammad Bashir, et al.
Publicado: (2020)

Lactococcus lactis M4, a potential host for the expression of heterologous proteins
por: Noreen, Nanyan, et al.
Publicado: (2011)

Monoclonal antibodies specific for the hemagglutinin-neuraminidase protein define neutralizing epitopes specific for Newcastle disease virus genotype 2.VII from Egypt
por: Moharam, Ibrahim, et al.
Publicado: (2021)

Diagnostic and Vaccination Approaches for Newcastle Disease Virus in Poultry: The Current and Emerging Perspectives
por: Bello, Muhammad Bashir, et al.
Publicado: (2018)

Corrigendum to “Safety and Clinical Usage of Newcastle Disease Virus in Cancer Therapy”
por: Lam, Han Yuen, et al.
Publicado: (2017)

Evaluation of Ultra-Microscopic Changes and Proliferation of Apoptotic Glioblastoma Multiforme Cells Induced by Velogenic Strain of Newcastle Disease Virus AF2240
por: Ali-Saeed, Rola, et al.
Publicado: (2019)

Preparation and diagnostic utility of a hemagglutination inhibition test antigen derived from the baculovirus-expressed hemagglutinin-neuraminidase protein gene of Newcastle disease virus
por: Choi, Kang-Seuk, et al.
Publicado: (2013)

Biological Significance of Dual Mutations A494D and E495K of the Genotype III Newcastle Disease Virus Hemagglutinin-Neuraminidase In Vitro and In Vivo
por: Lu, Xiaolong, et al.
Publicado: (2022)

Influenza Hemagglutinin and Neuraminidase Membrane Glycoproteins
por: Gamblin, Steven J., et al.
Publicado: (2010)

Inhibition of pathogenic and spoilage bacteria by a novel biofilm-forming Lactobacillus isolate: a potential host for the expression of heterologous proteins
por: Jalilsood, Tannaz, et al.
Publicado: (2015)

Immunization with recombinant enterovirus 71 viral capsid protein 1 fragment stimulated antibody responses in hamsters
por: Ch’ng, Wei-Choong, et al.
Publicado: (2012)

The Interplay between the Host Receptor and Influenza Virus Hemagglutinin and Neuraminidase
por: Byrd-Leotis, Lauren, et al.
Publicado: (2017)

Co-expression of the Hemagglutinin and Neuraminidase by Heterologous Newcastle Disease Virus Vectors Protected Chickens against H5 Clade 2.3.4.4 HPAI Viruses
por: Cho, Yeonwoo, et al.
Publicado: (2018)

Drivers of recombinant soluble influenza A virus hemagglutinin and neuraminidase expression in mammalian cells
por: van der Woude, Roosmarijn, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_d48ccb51hcf59rvl3m61e1eubr